Species Differences in Renal Development and Associated Developmental Nephrotoxicity

Kendall S Frazier1

  • 1GlaxoSmithKline, King of Prussia, Pennsylvania.

Birth Defects Research
|August 3, 2017
PubMed

Insights

The developing kidney is vulnerable to toxins during growth, leading to birth defects and functional impairments. Understanding species-specific developmental differences is crucial for assessing pediatric nephrotoxicity risks.

Area of Science:

  • Developmental toxicology
  • Nephrology
  • Comparative physiology

Background:

  • The developing kidney is susceptible to morphological and functional damage during gestation and early life.
  • Exposure to xenobiotics can cause congenital anomalies like aplasia, dysplasia, and polycystic kidney disease, or functional deficits.

Purpose of the Study:

  • To review the impact of teratogens and nephrotoxins on renal development.
  • To highlight species-specific differences in renal development and their implications for toxicity testing.
  • To discuss the translational relevance of animal studies to human pediatric nephrotoxicity.

Main Methods:

  • Literature review of developmental toxicology and nephrology studies.
  • Comparative analysis of renal development timelines and functional maturation across species.
  • Examination of genetic and molecular mechanisms underlying renal developmental anomalies.

Main Results:

  • Renal development is sensitive to environmental insults, causing structural and functional abnormalities.
  • Species-specific differences in nephrogenesis, transporter function, and metabolism influence toxicity outcomes.
  • Age-dependent changes in renal physiology impact drug tolerability and toxicity profiles.

Conclusions:

  • Understanding species and age-dependent variations in kidney development is essential for accurate risk assessment of environmental agents.
  • Advances in genetics and molecular biology enhance the mechanistic understanding of developmental nephrotoxicity.
  • Investigative studies provide critical data for evaluating pediatric nephrotoxic potential in humans.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
531
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
279
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
7.6K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
376
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.3K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
55